Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma

Abstract Cholangiocarcinoma (CCA) is an aggressive solid tumour with a 5-year survival rate ranging from 7% to 20%. It is, therefore, urgent to identify novel biomarkers and therapeutic targets to improve the outcomes of patients with CCA. SPRY-domain containing protein 4 (SPRYD4) contains SPRY doma...

詳細記述

書誌詳細

主要な著者:	Zuyi Ma, Tiange Xie, Jia Sun, Jianchun Yu, Shanzhou Huang, Qi Zhou, Binglu Li
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-05-01
シリーズ:	BMC Cancer
主題:	SPRYD4 Cholangiocarcinoma Tumor suppressor Prognosis Tumor immune infiltration
オンライン･アクセス:	https://doi.org/10.1186/s12885-023-10810-9
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!